Source Royal Holloway University: We are looking for volunteers with Relapsing Remitting MS to take part in a new study investigating the relationship between specific mental skills and employment in Multiple Sclerosis
Volunteers needed for Royal Holloway University employment research study Read More »
Source BBC: MS drug hope for secondary-progressive stage. A study of a new drug to treat advanced cases of multiple sclerosis suggests it may be possible to delay progression of the disease in the short term, although the effects were small.
Source BBC: A year on from gruelling stem cell treatment for her multiple sclerosis, BBC correspondent Caroline Wyatt reveals what effect the potentially life-changing “reboot” of her immune system has had on her life.
Caroline Wyatt – My quest to stop MS in its tracks Read More »
Source MS Society: Disease modifying therapy daclizumab (Zinbryta) has been withdrawn from sale worldwide. Its manufacturers took the decision after reports that a number of people taking the treatment developed serious inflammatory brain disorders.
Daclizumab withdrawn from NHS after safety concerns Read More »
A research request: I am a psychology student currently working on behalf of King’s with Professor Rona Moss-Morris and neurologist Dr Victoria Williams on a large scale project looking at fatigue in MS.
Research request from a psychology student Read More »
Source Multiple Sclerosis News Today: Inhibition of the neuroactive opioid growth factor (OGF) alters the blood levels of important pro- and anti-inflammatory proteins in mice with multiple sclerosis (MS)-like disease.
Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows Read More »
Opinion Health is currently conducting a study that involves patients with multiple sclerosis, and we would like to kindly ask for your support.
A £10 gesture of thanks offered to MS participants who complete survey Read More »
Source EurekAlert: Guardian molecule induced by testosterone reverses harmful immune response, eliminates disease symptoms in female mice.
Men hold secret to protect women from multiple sclerosis Read More »
Source MS Trust: NICE has recommended Extavia, but rejected Copaxone, Avonex, Betaferon, Plegridy and Rebif in its preliminary appraisal of MS drugs. The MS Trust has responded to NICE’s consultation in the strongest possible terms.
NICE proposes rejecting five drugs for relapsing MS – MS Trust responds Read More »
Source MS Society: Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.
Ocrelizumab licensed for people with early primary progressive MS in the UK Read More »
